Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-22

Clinical Trial Update: A Study to Compare the Blood Levels of Albaconazole in Healthy Subjects Who Have Received a Single Dose of 400 mg Albaconazole as a Tablet Versus Albaconazole as a Capsule [Phase 1]

View source ↗

Summary

Phase 1 study comparing the blood levels of albaconazole when given as a tablet versus a capsule in healthy subjects to evaluate pharmacokinetic bioavailability…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Albaconazole (albaconazole)

Snippet

Sponsor: Stiefel, a GSK Company | Conditions: Onychomycosis | Phase 1 | Status: COMPLETED